Skip navigation

Chemical Triazenes

1–50 of 149 results.
  Chemical Phenotype Co-Mentioned Terms Interaction Organisms Anatomy Inference Network References
1. 1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene positive regulation of cell death 1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene results in increased positive regulation of cell death 1: Rattus norvegicus Fetus | Cerebral Cortex | Neurons | Cells, Cultured   1
2. 1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene positive regulation of cell death Thiopental Thiopental inhibits the reaction [1-hydroxy-2-oxo-3-(3-aminopropyl)-3-isopropyl-1-triazene results in increased positive regulation of cell death] 1: Rattus norvegicus Fetus | Cerebral Cortex | Neurons | Cells, Cultured   1
3. 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene stem cell differentiation 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene results in increased stem cell differentiation 1: Mus musculus Embryonic Stem Cells
2 genes: KIT | PDX1
1
4. 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene positive regulation of leukocyte adhesion to vascular endothelial cell IL1B | lipopolysaccharide, Escherichia coli O111 B4 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased positive regulation of leukocyte adhesion to vascular endothelial cell] 1: Homo sapiens Neutrophils | Human Umbilical Vein Endothelial Cells | Cells, Cultured 1 gene: MIR21 1
5. 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene positive regulation of leukocyte adhesion to vascular endothelial cell IL1B | lipopolysaccharide, Escherichia coli O111 B4 | Nitric Oxide Nitric Oxide deficiency inhibits the reaction [1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene inhibits the reaction [[lipopolysaccharide, Escherichia coli O111 B4 co-treated with IL1B protein] results in increased positive regulation of leukocyte adhesion to vascular endothelial cell]] 1: Homo sapiens Neutrophils | Human Umbilical Vein Endothelial Cells | Cells, Cultured 1 gene: MIR21 1
6. 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene cell proliferation 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene results in decreased cell proliferation 1: Homo sapiens Pulmonary Artery | Myocytes, Smooth Muscle | Cells, Cultured
6 genes: AKT1 | BAK1 | BAX | GNL3 | NUMB | TP53
1
7. 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene cell proliferation 2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one [2-(3,4-dimethoxybenzyl)-7-(1-(1-hydroxyethyl)-4-phenylbutyl)-5-methylimidazo(5,1-f)(1,2,4)triazin-4 (3H)-one co-treated with 1-hydroxy-2-oxo-3,3-bis(2-aminoethyl)-1-triazene] results in decreased cell proliferation 1: Homo sapiens Pulmonary Artery | Myocytes, Smooth Muscle | Cells, Cultured
6 genes: AKT1 | BAK1 | BAX | GNL3 | NUMB | TP53
1
8. (1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl-3-aminopropyl)-3-methyl-1-triazene apoptotic process Nitric Oxide [(1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl-3-aminopropyl)-3-methyl-1-triazene results in increased abundance of Nitric Oxide] which results in increased apoptotic process 1: Mus musculus Insulin-Secreting Cells | Cell Line   1
9. (1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl-3-aminopropyl)-3-methyl-1-triazene protein nitrosylation (1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl-3-aminopropyl)-3-methyl-1-triazene results in increased protein nitrosylation 1: Homo sapiens Hepatocytes | Cell Line, Tumor   1
10. (1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl-3-aminopropyl)-3-methyl-1-triazene protein nitrosylation KEAP1 [(1-hydroxy-2-oxo-3-(N-methyl-3-aminopropyl)-3-methyl-3-aminopropyl)-3-methyl-1-triazene results in increased protein nitrosylation] which results in increased expression of KEAP1 protein modified form 1: Homo sapiens Hepatocytes | Cell Line, Tumor   1
11. Dacarbazine apoptotic process Dacarbazine results in increased apoptotic process 1: Homo sapiens Epidermis
12 genes: BIRC5 | CASP3 | CASP8 | EPO | IFNA2 | IFNG | IRF1 | MAPK1 | MAPK3 | MCL1 | TNF | TNFSF10
1
12. Dacarbazine apoptotic process TNFSF10 [TNFSF10 co-treated with Dacarbazine] results in increased apoptotic process 1: Homo sapiens Epidermis | Cell Line, Tumor
12 genes: BIRC5 | CASP3 | CASP8 | EPO | IFNA2 | IFNG | IRF1 | MAPK1 | MAPK3 | MCL1 | TNF | TNFSF10
1
13. Dacarbazine apoptotic process Dacarbazine results in increased apoptotic process 1: Mus musculus Intestine, Small | Epithelium
12 genes: BIRC5 | CASP3 | CASP8 | EPO | IFNA2 | IFNG | IRF1 | MAPK1 | MAPK3 | MCL1 | TNF | TNFSF10
1
14. Dacarbazine apoptotic process O(6)-benzylguanine O(6)-benzylguanine inhibits the reaction [Dacarbazine results in increased apoptotic process] 1: Mus musculus Intestine, Small | Epithelium
12 genes: BIRC5 | CASP3 | CASP8 | EPO | IFNA2 | IFNG | IRF1 | MAPK1 | MAPK3 | MCL1 | TNF | TNFSF10
1
15. Dacarbazine apoptotic process Metyrapone Metyrapone inhibits the reaction [Dacarbazine results in increased apoptotic process] 1: Mus musculus Intestine, Small | Epithelium
12 genes: BIRC5 | CASP3 | CASP8 | EPO | IFNA2 | IFNG | IRF1 | MAPK1 | MAPK3 | MCL1 | TNF | TNFSF10
1
16. Dacarbazine cellular response to light stimulus Dacarbazine results in increased cellular response to light stimulus 1: Rattus norvegicus Skin   1
17. Dacarbazine cellular response to light stimulus Dacarbazine results in increased cellular response to light stimulus 1: Rattus norvegicus Cornea   1
18. Dacarbazine cell death Dacarbazine results in increased cell death 1: Homo sapiens Skin | Cell Line, Tumor   1
19. Dacarbazine ATP biosynthetic process Dacarbazine results in decreased ATP biosynthetic process 1: Homo sapiens Hep G2 Cells   1
20. Diminazene regulation of blood pressure Diminazene results in decreased regulation of blood pressure 1: Rattus norvegicus Blood Vessels   1
21. Diminazene regulation of blood pressure Norepinephrine Diminazene inhibits the reaction [Norepinephrine results in increased regulation of blood pressure] 1: Rattus norvegicus Blood Vessels   1
22. diminazene aceturate regulation of heart rate diminazene aceturate results in increased regulation of heart rate 1: Canis lupus familiaris Cardiovascular System 1 gene: AGT 1
23. diminazene aceturate regulation of cholesterol metabolic process diminazene aceturate affects regulation of cholesterol metabolic process 1: Mus musculus Blood   1
24. diminazene aceturate regulation of cholesterol metabolic process Cholesterol, VLDL [diminazene aceturate affects regulation of cholesterol metabolic process] which results in decreased abundance of Cholesterol, VLDL 1: Mus musculus Blood   1
25. Temozolomide cell proliferation Temozolomide results in decreased cell proliferation 1: Homo sapiens Skin | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
26. Temozolomide cell proliferation Pyrimethamine Pyrimethamine promotes the reaction [Temozolomide results in decreased cell proliferation] 1: Homo sapiens Skin | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
27. Temozolomide cell cycle Pyrimethamine [Pyrimethamine co-treated with Temozolomide] results in decreased cell cycle 1: Homo sapiens Skin | Cell Line, Tumor
24 genes: ATM | BECN1 | BIRC5 | BRCA2 | CCNB1 | CCND1 | CDC25C | CDK1 | CDKN1A | CDKN1B | CDKN1C | CHEK1 | CHEK2 | FANCD2 | H2AFX | MLH1 | MSH2 | PIK3C3 | RB1 | RGCC | TFDP1 | TP53 | TRP53 | WEE1
1
28. Temozolomide apoptotic process Pyrimethamine [Pyrimethamine co-treated with Temozolomide] results in increased apoptotic process 1: Homo sapiens Skin | Cell Line, Tumor
37 genes: AKT1 | ATM | BAX | BCL2 | BCL2L1 | BCL2L11 | BECN1 | BIRC5 | CADM1 | CASP12 | CASP3 | CASP7 | CASP8 | CASP9 | CDK1 | CHEK1 | CHEK2 | ELMO1 | FASLG | IL24 | NFKBIA | PARP1 | PHLDA1 | PMAIP1 | POLB | PPP1R15A | RB1 | SEMA3A | TCIM | TNF | TNFAIP3 | TNFRSF19 | TNFSF10 | TP53 | TRP53 | XAF1 | XIAP
1
29. Temozolomide apoptotic process Leucovorin | Pyrimethamine Leucovorin inhibits the reaction [[Temozolomide co-treated with Pyrimethamine] results in increased apoptotic process] 1: Homo sapiens Skin | Cell Line, Tumor
37 genes: AKT1 | ATM | BAX | BCL2 | BCL2L1 | BCL2L11 | BECN1 | BIRC5 | CADM1 | CASP12 | CASP3 | CASP7 | CASP8 | CASP9 | CDK1 | CHEK1 | CHEK2 | ELMO1 | FASLG | IL24 | NFKBIA | PARP1 | PHLDA1 | PMAIP1 | POLB | PPP1R15A | RB1 | SEMA3A | TCIM | TNF | TNFAIP3 | TNFRSF19 | TNFSF10 | TP53 | TRP53 | XAF1 | XIAP
1
30. Temozolomide cell death benzyl isothiocyanate benzyl isothiocyanate promotes the reaction [Temozolomide results in increased cell death] 1: Homo sapiens Skin | Cell Line, Tumor 1 gene: CDKN1B 1
31. Temozolomide cell death Chlorhexidine Chlorhexidine promotes the reaction [Temozolomide results in increased cell death] 1: Homo sapiens Skin | Cell Line, Tumor 1 gene: CDKN1B 1
32. Temozolomide cell death cloxyquin cloxyquin promotes the reaction [Temozolomide results in increased cell death] 1: Homo sapiens Skin | Cell Line, Tumor 1 gene: CDKN1B 1
33. Temozolomide cell death 3,4-dimethoxydalbergione 3,4-dimethoxydalbergione promotes the reaction [Temozolomide results in increased cell death] 1: Homo sapiens Skin | Cell Line, Tumor 1 gene: CDKN1B 1
34. Temozolomide cell death Pyrimethamine Pyrimethamine promotes the reaction [Temozolomide results in increased cell death] 1: Homo sapiens Skin | Cell Line, Tumor 1 gene: CDKN1B 1
35. Temozolomide cell death Triamterene Triamterene promotes the reaction [Temozolomide results in increased cell death] 1: Homo sapiens Skin | Cell Line, Tumor 1 gene: CDKN1B 1
36. Temozolomide cell death Temozolomide results in increased cell death 1: Homo sapiens Skin | Cell Line, Tumor 1 gene: CDKN1B 2
37. Temozolomide DNA catabolic process Pyrimethamine [Pyrimethamine co-treated with Temozolomide] results in increased DNA catabolic process 1: Homo sapiens Skin | Cell Line, Tumor   1
38. Temozolomide cell proliferation Pyrimethamine [Pyrimethamine co-treated with Temozolomide] results in decreased cell proliferation 1: Homo sapiens Skin | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
39. Temozolomide cell proliferation etoprine [etoprine co-treated with Temozolomide] results in decreased cell proliferation 1: Homo sapiens Skin | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
40. Temozolomide cell proliferation metoprine [metoprine co-treated with Temozolomide] results in decreased cell proliferation 1: Homo sapiens Skin | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
41. Temozolomide cell proliferation Methotrexate [Methotrexate co-treated with Temozolomide] results in decreased cell proliferation 1: Homo sapiens Skin | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
42. Temozolomide cell proliferation Pyrimethamine [Pyrimethamine co-treated with Temozolomide] results in decreased cell proliferation 1: Homo sapiens Neuroglia | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
43. Temozolomide cell proliferation etoprine [etoprine co-treated with Temozolomide] results in decreased cell proliferation 1: Homo sapiens Neuroglia | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
44. Temozolomide cell proliferation metoprine [metoprine co-treated with Temozolomide] results in decreased cell proliferation 1: Homo sapiens Neuroglia | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
45. Temozolomide cell proliferation Methotrexate [Methotrexate co-treated with Temozolomide] results in decreased cell proliferation 1: Homo sapiens Neuroglia | Cell Line, Tumor
15 genes: AKT1 | BAX | BCL2 | BCL2L1 | BRCA2 | CDC25C | CDK1 | CSGALNACT1 | CXCL1 | EDNRA | FGF2 | PRL | TFDP1 | TP53 | VEGFA
1
46. Temozolomide autophagy Gossypol [Gossypol co-treated with Temozolomide] results in increased autophagy 1: Homo sapiens Astrocytes | Cell Line, Tumor
7 genes: BECN1 | FBXO32 | MAP1LC3B | PIK3C3 | PRKAA2 | TP53 | TRP53
1
47. Temozolomide cell cycle Temozolomide results in decreased cell cycle 1: Homo sapiens Neuroglia | Cell Line, Tumor
24 genes: ATM | BECN1 | BIRC5 | BRCA2 | CCNB1 | CCND1 | CDC25C | CDK1 | CDKN1A | CDKN1B | CDKN1C | CHEK1 | CHEK2 | FANCD2 | H2AFX | MLH1 | MSH2 | PIK3C3 | RB1 | RGCC | TFDP1 | TP53 | TRP53 | WEE1
3
48. Temozolomide cell cycle O(6)-benzylguanine [Temozolomide co-treated with O(6)-benzylguanine] results in decreased cell cycle 1: Homo sapiens Brain | Cell Line, Tumor
24 genes: ATM | BECN1 | BIRC5 | BRCA2 | CCNB1 | CCND1 | CDC25C | CDK1 | CDKN1A | CDKN1B | CDKN1C | CHEK1 | CHEK2 | FANCD2 | H2AFX | MLH1 | MSH2 | PIK3C3 | RB1 | RGCC | TFDP1 | TP53 | TRP53 | WEE1
1
49. Temozolomide apoptotic process Temozolomide results in increased apoptotic process 1: Mus musculus Intestine, Small | Epithelium
37 genes: AKT1 | ATM | BAX | BCL2 | BCL2L1 | BCL2L11 | BECN1 | BIRC5 | CADM1 | CASP12 | CASP3 | CASP7 | CASP8 | CASP9 | CDK1 | CHEK1 | CHEK2 | ELMO1 | FASLG | IL24 | NFKBIA | PARP1 | PHLDA1 | PMAIP1 | POLB | PPP1R15A | RB1 | SEMA3A | TCIM | TNF | TNFAIP3 | TNFRSF19 | TNFSF10 | TP53 | TRP53 | XAF1 | XIAP
1
50. Temozolomide apoptotic process Temozolomide results in increased apoptotic process 1: Homo sapiens Astrocytes | Cell Line, Tumor
37 genes: AKT1 | ATM | BAX | BCL2 | BCL2L1 | BCL2L11 | BECN1 | BIRC5 | CADM1 | CASP12 | CASP3 | CASP7 | CASP8 | CASP9 | CDK1 | CHEK1 | CHEK2 | ELMO1 | FASLG | IL24 | NFKBIA | PARP1 | PHLDA1 | PMAIP1 | POLB | PPP1R15A | RB1 | SEMA3A | TCIM | TNF | TNFAIP3 | TNFRSF19 | TNFSF10 | TP53 | TRP53 | XAF1 | XIAP
1
1–50 of 149 results.